0001104659-07-036963.txt : 20070508 0001104659-07-036963.hdr.sgml : 20070508 20070508152615 ACCESSION NUMBER: 0001104659-07-036963 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070508 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070508 DATE AS OF CHANGE: 20070508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cellu Tissue Holdings, Inc. CENTRAL INDEX KEY: 0001295976 STANDARD INDUSTRIAL CLASSIFICATION: PAPER MILLS [2621] IRS NUMBER: 061346495 STATE OF INCORPORATION: DE FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-118829 FILM NUMBER: 07827942 BUSINESS ADDRESS: STREET 1: 3442 FRANCIS ROAD STREET 2: SUITE 220 CITY: ALPHARETTA STATE: GA ZIP: 30004 BUSINESS PHONE: (678)393-2651 MAIL ADDRESS: STREET 1: 3442 FRANCIS ROAD STREET 2: SUITE 220 CITY: ALPHARETTA STATE: GA ZIP: 30004 8-K 1 a07-13616_18k.htm 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) May 8, 2007

Cellu Tissue Holdings, Inc.
(Exact name of registrant as specified in its charter)

Delaware	333-118829	06-1346495
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)

1855 Lockeway Drive
Suite 501
Alpharetta, Georgia		30004
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code (678) 393-2651

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;

Cellu Tissue Holdings, Inc. announced today that Dianne M. Scheu, chief financial officer, is retiring from the Company.

The press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.

Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS

The following is being furnished as an exhibit to this Current Report on Form 8-K:

(d) Exhibits

99.1 Release, dated May 8, 2007, “Cellu Tissue Holdings, Inc.
Announces Departure of Chief Financial Officer” furnished pursuant to Item 5.02

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Cellu Tissue Holdings, Inc.
	(Registrant)


Date: Mary 8, 2007	By:	/s/ Dianne M. Scheu
	Ms. Dianne M. Scheu
	Senior Vice President, Finance and Chief Financial Officer

Page 2

EXHIBIT INDEX

99.1 Release, dated May 8, 2007, “Cellu Tissue Holdings, Inc.
Announces Departure of Chief Financial Officer”

Page 3

EX-99.1 2 a07-13616_1ex99d1.htm EX-99.1

Exhibit 99.1

FOR IMMEDIATE RELEASE

Cellu Tissue Holdings, Inc. Announces Departure of Chief Financial Officer

Alpharetta, Georgia - May 8, 2007 — Cellu Tissue Holdings, Inc. (the “Company” or “Cellu Tissue”) announced today that Dianne M. Scheu, chief financial officer, is retiring from the Company.

“Dianne has played a significant role in the growth and development of Cellu Tissue and her leadership and counsel will be greatly missed within the organization,” said Russell C. Taylor, president and chief executive officer. “Dianne has stated that she will retire at some point this summer, but a specific date has not been set because of her willingness to be flexible based upon Cellu Tissue’s operational needs. Dianne’s flexibility in this regard is indicative of her devotion and commitment to the organization. I will especially miss her as our working relationship has spanned over 10 years. We all wish her the best.”

With Ms. Scheu’s assistance, the Company has commenced a search for a new chief financial officer. In the interim, Ms. Scheu will continue to function as the chief financial officer and all reporting relationships currently in place will remain.

Cellu Tissue Holdings, Inc. is a manufacturer of a variety of specialty tissue hard rolls and machine-glazed paper used in the manufacture of various end products, including diapers, facial and bath tissue, assorted paper towels and food wraps. In addition, the Company produces a variety of converted tissue products. Cellu Tissue’s customers include major North American producers of branded and unbranded disposable consumer absorbent and tissue products for the personal and health care markets; consumer and away-from-home tissue products companies; national and regional tissue products distributors; and third-party converters who sell their products to food, bakery and confections companies. Cellu Tissue services a diverse group of high-quality customers, with three of its top 10 customers belonging to the Fortune 150 group of companies. For more information, contact Cellu Tissue Holdings, Inc at www.cellutissue.com.